Showing results (41-50 of 51) with videos related to
Sort By:
Pageof 6
The Medical Journal of Australia|February 2, 2018
Diagnosis and management of idiopathic pulmonary fibrosis: Thoracic Society of Australia and New Zealand and Lung Foundation Australia position statements summaryHelen E Jo, Jyotika D Prasad, Lauren K Troy, et al.Respirology (Carlton, Vic.)|November 24, 2020
Diagnosis and management of connective tissue disease-associated interstitial lung disease in Australia and New Zealand: A position statement from the Thoracic Society of Australia and New ZealandAdelle S Jee, Robert Sheehy, Peter Hopkins, et al.The European Respiratory Journal|March 7, 2020
Mepolizumab effectiveness and identification of super-responders in severe asthmaErin S Harvey, David Langton, Constance Katelaris, et al.Internal Medicine Journal|June 4, 2026
Idiopathic Pulmonary Fibrosis update, comparing the Australasian Interstitial Lung Disease Registry to the Australian Idiopathic Pulmonary Fibrosis RegistryMichelle Chee, Yet Hong Khor, Dan Jackson, et al.Respirology (Carlton, Vic.)|October 18, 2018
Implications of the diagnostic criteria of idiopathic pulmonary fibrosis in clinical practice: Analysis from the Australian Idiopathic Pulmonary Fibrosis RegistryHelen E Jo, Ian Glaspole, Nicole Goh, et al.Thorax|September 24, 2024
Implications of the 2022 lung function update and GLI global reference equations among patients with interstitial lung diseaseAndrew Li, Alan Teoh, Lauren Troy, et al.The European Respiratory Journal|October 22, 2021
Biomarker signatures for progressive idiopathic pulmonary fibrosisBritt Clynick, Tamera J Corte, Helen E Jo, et al.Cancers|February 24, 2024
Evaluation of Endobronchial Ultrasound-Guided Transbronchial Needle Aspiration (EBUS-TBNA) Samples from Advanced Non-Small Cell Lung Cancer for Whole Genome, Whole Exome and Comprehensive Panel SequencingDavid Fielding, Vanessa Lakis, Andrew J Dalley, et al.The Lancet. Respiratory Medicine|October 4, 2019
Diagnostic accuracy of transbronchial lung cryobiopsy for interstitial lung disease diagnosis (COLDICE): a prospective, comparative studyLauren K Troy, Christopher Grainge, Tamera J Corte, et al.The Journal of Allergy and Clinical Immunology. in Practice|February 5, 2021
Mepolizumab and Oral Corticosteroid Stewardship: Data from the Australian Mepolizumab RegistryDennis Thomas, Erin S Harvey, Vanessa M McDonald, et al.Pageof 6